Researchers engineered a strain of non-pathogenic bacteria that colonize solid tumors and safely deliver immunotherapies, acting as a Trojan horse. The therapy led not only to complete tumor regression in a mouse model of lymphoma, but also significant control of distant, uninjected tumor lesions.

Researchers engineered a strain of non-pathogenic bacteria that colonize solid tumors and safely deliver immunotherapies, acting as a Trojan horse. The therapy led not only to complete tumor regression in a mouse model of lymphoma, but also significant control of distant, uninjected tumor lesions.: https://ift.tt/2Ja72Ac Read more... https://ift.tt/2Xkv3YT